期刊文献+

术前输注头孢呋辛钠后不同靶控浓度丙泊酚对妇科手术患者心室复极的影响 被引量:4

Effects of target-controlled infusion of propofol with different concentrations on ventricular repolarization after preoperative infusion of cefuroxime sodium in patients undergoing gynecologic operation
下载PDF
导出
摘要 目的观察术前预防性输注头孢呋辛钠后不同靶控浓度丙泊酚对妇科手术患者心室复极的影响。方法选择择期妇科手术患者59例,年龄18~65岁,ASAⅠ或Ⅱ级,采用随机数字表法分为三组。入室补液并静滴头孢呋辛钠2.5g(溶于100ml生理盐水中)后,分别泵注丙泊酚血浆靶控浓度为2μg/ml(P2组,n=20)、3μg/ml(P3组,n=19)、4μg/ml(P4组,n=20)。分别在抗生素输注前(T_0)、抗生素输注完毕(T_1)、及丙泊酚达到靶控浓度时(T_2),测量并计算QT间期、QTc间期、T波峰值至终点时间(T_p-e间期)及Tp-e/QT。结果与T0时比较,T_1时P4组QTc间期[(469.9±34.0)ms vs.(451.2±24.9)ms]、Tp-e间期[(107±25)ms vs.(94±20)ms]、Tp-e/QT(0.260±0.058vs.0.236±0.043)明显延长(P〈0.05);与T_1时比较,T_2时P2组[(437.4±24.4)ms vs.(453.3±28.0)ms]和P4组[(438.8±29.9)ms vs.(469.9±34.0)ms]QTc间期明显缩短(P〈0.05)。结论丙泊酚可改善头孢呋辛钠引起的心室复极不均一性。 Objective To investigate the effects of target-controlled confusion of propofol with different concentrations on ventricular repolarization after prophylactic infusion of cefuroxime sodium.Methods Sixty ASA physical status Ⅰ orⅡ female patients,aged 18-65 years,undergoing elective gynecological surgery were randomly divided into three groups:group P2(n=20)with TCI 2μg/ml,group P3(n=19)with TCI 3μg/ml and group P4(n=20)with TCI 4μg/ml.Firstly,they were rehydrated;secondly,the patients in groups P2,P3 and P4were intravenous infused with cefuroxime sodium 2.5g(in 100 ml normal saline)and then target-controlled infused of propofol 2μg/ml,3μg/ml and 4μg/ml in target plasma concentration,respectively.At three pionts of time:after rehydration before intravenous antibiotics(T_0),after intravenous antibiotics before TCI of propofol(T_1),after TCI of propofol(T_2),QT_ interval,QTc interval,T_p-e interval were measured and recorded,respectively.Results Compared with T_0,QTc [(469.9±34.0)ms vs.(451.2±24.9)ms],T_p-e[(107±25)ms vs.(94±20)ms]and T_p-e/QT_(0.260±0.058 vs.0.236±0.043)in group P4 were significantly prolonged at T_1(P〈0.05).Compared with T_1,QTc of groups P2 [(437.4±24.4)ms vs.(453.3±28.0)ms]and P4[(438.8±29.9)ms vs.(469.9±34.0)ms]were shortened significantly at T_2(P〈0.05).Conclusion Propofol could improve ventricular reporlarization heterogeneity caused by cefuroxime sodium.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2016年第12期1177-1179,共3页 Journal of Clinical Anesthesiology
基金 贵阳市科技计划项目(筑科合同[2015001]社引号)
关键词 头孢呋辛钠 丙泊酚 T波峰值至终点时间 QT间期 Cefuroxime sodium Propofol Tp-e interval QT interval
  • 相关文献

参考文献1

二级参考文献17

  • 1Van GX, Lankipalli RS, Burke JF, Musco S, Kowey PRo Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coli Cardiol 2003; 42: 401-9.
  • 2Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013-22.
  • 3Strnadova C. The assessment of QT/QTc interval prolongation in clinical trials: a regulatory perspective. Drug Information J 2005; 39: 407-33.
  • 4International Conference on Harmonisation (ICH). ICH topic E14. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs (Step 4). 12 May 2005. Ava ilable from: http://www.ich.org,lfileadmin/Public_Web_Site/ICH_ Products/Guidelines/Efficacy/E14/E14_Guideline.pdf (last accessed on 10 September 2012).
  • 5E14 implementation working group: ICH E14 guideline: the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs questions & answers (R1). 5 April 2012. available from: http://www.ich.org,lfileadmin/Public_Web_Site/ICH_ Products/Guidelines/Efficacy/E14/E14_Q_As_R1_step4.pdf (last accessed on 10 September 2012).
  • 6Darpo B. The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance. Br J Pharmacol2010; 159: 49-57.
  • 7Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF. Effects of three fluoroquinolones on QT analysis after standard treatment courses. Ann Noninvasive Electrocardiol 2006; 11: 52-6.
  • 8Van BF, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009; 32: 359- 78.
  • 9Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920; 53: 469-86.
  • 10Malik M. Problems of heart rate correction in assessment of drug?induced QT interval prolongation. J Cardiovasc Electrophysiol 2001; 12: 411-20.

共引文献6

同被引文献34

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部